Clinical research at IOSI
The Clinical Research Unit (CRU-IOSI), is responsible for the management and coordination of clinical trials with investigational therapies at all stages of development. The CRU-IOSI is the point of contact for all matters pertaining to the conduct of clinical research and supports investigators and various research groups with the goal of improving the quality of clinical research by encouraging a culture of innovation.
IOSI'sNew Drug Development Unit, based at the San Giovanni Hospital in Bellinzona, is specifically dedicated to developing and conducting phase I clinical trials, including clinical trials with drugs never before tested in humans ("first-in-human") aimed at evaluating new drugs and/or innovative therapeutic approaches.
These units have highly qualified medical and nursing staff with long experience in conducting clinical trials at all stages of development (phase I-III studies and translational studies). They collaborate with all units and physicians at IOSI for patients included in clinical trials and with national and international consortia, institutes and research groups to conduct multicenter clinical trials.
The main themes of clinical research at IOSI are new drug development, prostate cancer and lymphatic neoplasms.
Other research topics include breast cancer, lung cancer, research in hematology, gastrointestinal cancers, gynecological cancers, melanomas, and research in radiation therapy.
